Get started
Award

RD06/0020

Funded outputs count: 62
Funder award ID: RD06/0020
OpenAlex ID: G3970580488
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025 · Daniel R. Barnes, Jonathan P. Tyrer, et al. · npj Genomic Medicine · 1
PDF
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025 · Barnes, Daniel R, Tyrer, Jonathan P, et al. · eScholarship (California Digital Library)
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2024 · Clarke, C.L., Anton-Culver, H., et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2024 · Castelao, J.E., Geisler, J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
2023 · Pooja Middha, Xiaoliang Wang, et al. · Breast Cancer Research · 14
PDF
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
2023 · Hagai Levi, Shai Carmi, et al. · Journal of Medical Genetics · 4
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
2023 · Mark van Barele, Delal Akdeniz, et al. · JNCI Journal of the National Cancer Institute · 11
PDF
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
2023 · Stefanie H. Mueller, Alvina G. Lai, et al. · Genome Medicine · 15
PDF
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 29
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2022 · Suzanne C Dixon-Suen, Sarah J Lewis, et al. · British Journal of Sports Medicine · 88
Rare germline copy number variants (CNVs) and breast cancer risk
2022 · Joe Dennis, Jonathan P. Tyrer, et al. · Communications Biology · 15
PDF
Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study
2021 · Aayah Nounu, Rebecca C Richmond, et al. · Nutrients · 11
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2021 · Maria Escala-Garcia, Sander Canisius, et al. · Scientific Reports · 5
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2021 · Anna Morra, Maria Escala-Garcia, et al. · Breast Cancer Research · 22
PDF
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
2021 · Hanla A. Park, Sonja Neumeyer, et al. · British Journal of Cancer · 22
PDF
Using genetics to uncouple higher adiposity from its adverse metabolic effects and understand its role in metabolic and non-metabolic disease.
2021 · Susan Martin, Jessica Tyrrell, et al. · Research Square
PDF
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
2021 · Juliette Coignard, Michael Lush, et al. · Nature Communications · 40
PDF
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
2021 · NBCS Collaborators, Nichola Johnson, et al. · British Journal of Cancer · 9
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
2020 · Caroline J. Bull, Joshua A. Bell, et al. · BMC Medicine · 166
PDF
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
2020 · Cook, M., Lalloo, F., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2
PDF
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers
2020 · Rosenquist, Richard, Harbst, Katja, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
2020 · Jingjing Liu, Wendy J. C. Prager - van der Smissen, et al. · Scientific Reports · 6
PDF
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
2020 · Caroline J. Bull, Joshua A. Bell, et al. · medRxiv · 19
PDF
Year
Topic